“…Moreover, the results obtained in our animal model are also in line with the active implication of NADPH oxidases in the apoptotic death induced by doxorubicin to cardiomyocytes in vitro reported by Gilleron et al, (2009). Nox2 and Nox4 are the major isoforms of Nox expressed in cardiac tissue (Santos et al 2011), but previous works have pointed out that Nox2 is the isoform activated in doxorubicin cardiotoxicity (Deng et al 2007;Yoshida et al 2009;Huelsenbeck et al 2011) as well as in cardiac hypertrophy (Santos et al, 2011;Takemoto et al, 2001). Our results exclude up-regulation of the expression of the main Nox2 subunits gp91phox and p22phox, but it is to be noted that recruitment of cytosolic subunits of Nox2 expressed in heart tissue can lead to the observed activation of this enzyme by doxorubicin treatment, as pointed out by Yoshida et al, 2009 and Huelsenbeck et al, 2011.…”